Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ping-I Hsu

Showing results (171-180 of 205) with videos related to

Pageof 21
Sort By:
Helicobacter|July 17, 2010
Rabeprazole can overcome the impact of CYP2C19 polymorphism on quadruple therapyChao-Hung Kuo, Sophie S W Wang, Wen-Hung Hsu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|October 1, 2003
Clip-assisted endoscopic method for placement of a nasoenteric feeding tube into the distal duodenumChang-Bih Shie, Ping-I Hsu, Gin-Ho Lo, et al.
World Journal of Gastroenterology|December 12, 2003
Endoscopic banding ligation can effectively resect hyperplastic polyps of stomachChing-Chu Lo, Ping-I Hsu, Gin-Ho Lo, et al.
Journal of Clinical Gastroenterology|May 19, 2009
Comparison of hemostatic efficacy for argon plasma coagulation and distilled water injection in treating high-risk bleeding ulcersHuay-Min Wang, Ping-I Hsu, Gin-Ho Lo, et al.
Journal of Gastroenterology and Hepatology|March 14, 2020
Equivalent efficacies of reverse hybrid and concomitant therapies in first-line treatment of Helicobacter pylori infectionPing-I Hsu, Feng-Woei Tsay, John Y Kao, et al.
Anticancer Research|August 21, 2003
Compartment theory in Helicobacter pylori-associated gastric carcinogenesisHui-Hwa Tseng, Ping-I Hsu, Hui-Chun Chen, et al.
Journal of the Chinese Medical Association : JCMA|July 13, 2004
Comparison of cetraxate-based and pantoprazole-based triple therapies in the treatment of Helicobacter pylori infectionChung-Jen Wu, Ping-I Hsu, Gin-Ho Lo, et al.
The Kaohsiung Journal of Medical Sciences|June 18, 2013
Randomized trial comparing rabeprazole- versus lansoprazole-based Helicobacter pylori eradication regimensMeng-Kwan Liu, I-Chen Wu, Chien-Yu Lu, et al.
Helicobacter|September 17, 2013
Ten-day Quadruple therapy comprising proton-pump inhibitor, bismuth, tetracycline, and levofloxacin achieves a high eradication rate for Helicobacter pylori infection after failure of sequential therapyPing-I Hsu, Wen-Chi Chen, Feng-Woei Tsay, et al.
The American Journal of Gastroenterology|November 11, 2005
A prospective randomized trial of esomeprazole- versus pantoprazole-based triple therapy for Helicobacter pylori eradicationPing-I Hsu, Kwok-Hung Lai, Chiun-Ku Lin, et al.
Pageof 21

Showing results (171-180 of 205) with videos related to

Sort By:
Pageof 21
Helicobacter|July 17, 2010
Rabeprazole can overcome the impact of CYP2C19 polymorphism on quadruple therapyChao-Hung Kuo, Sophie S W Wang, Wen-Hung Hsu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|October 1, 2003
Clip-assisted endoscopic method for placement of a nasoenteric feeding tube into the distal duodenumChang-Bih Shie, Ping-I Hsu, Gin-Ho Lo, et al.
World Journal of Gastroenterology|December 12, 2003
Endoscopic banding ligation can effectively resect hyperplastic polyps of stomachChing-Chu Lo, Ping-I Hsu, Gin-Ho Lo, et al.
Journal of Clinical Gastroenterology|May 19, 2009
Comparison of hemostatic efficacy for argon plasma coagulation and distilled water injection in treating high-risk bleeding ulcersHuay-Min Wang, Ping-I Hsu, Gin-Ho Lo, et al.
Journal of Gastroenterology and Hepatology|March 14, 2020
Equivalent efficacies of reverse hybrid and concomitant therapies in first-line treatment of Helicobacter pylori infectionPing-I Hsu, Feng-Woei Tsay, John Y Kao, et al.
Anticancer Research|August 21, 2003
Compartment theory in Helicobacter pylori-associated gastric carcinogenesisHui-Hwa Tseng, Ping-I Hsu, Hui-Chun Chen, et al.
Journal of the Chinese Medical Association : JCMA|July 13, 2004
Comparison of cetraxate-based and pantoprazole-based triple therapies in the treatment of Helicobacter pylori infectionChung-Jen Wu, Ping-I Hsu, Gin-Ho Lo, et al.
The Kaohsiung Journal of Medical Sciences|June 18, 2013
Randomized trial comparing rabeprazole- versus lansoprazole-based Helicobacter pylori eradication regimensMeng-Kwan Liu, I-Chen Wu, Chien-Yu Lu, et al.
Helicobacter|September 17, 2013
Ten-day Quadruple therapy comprising proton-pump inhibitor, bismuth, tetracycline, and levofloxacin achieves a high eradication rate for Helicobacter pylori infection after failure of sequential therapyPing-I Hsu, Wen-Chi Chen, Feng-Woei Tsay, et al.
The American Journal of Gastroenterology|November 11, 2005
A prospective randomized trial of esomeprazole- versus pantoprazole-based triple therapy for Helicobacter pylori eradicationPing-I Hsu, Kwok-Hung Lai, Chiun-Ku Lin, et al.
Pageof 21